SKVI
What one share of Skinvisible holds
Pharmaceutical Preparations
Pharmaceuticals Inc., are a pharmaceutical research and development (“R&D”) company that has developed and patented an innovative polymer delivery system, Invisicare® and formulated over forty topical skin products, which we out-license globally.
Skinvisible’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.19 |
| Cash and investments | $0.00 |
| Debt | $0.07 |
| Book value | −$2.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$0.60 | — | $0.01 | — | −$0.41 |
| 2011 | — | −$0.67 | — | −$0.09 | — | −$0.34 |
| 2012 | — | −$0.67 | — | −$0.25 | — | −$0.74 |
| 2013 | — | −$0.61 | — | −$0.34 | — | −$1.23 |
| 2014 | — | −$0.86 | — | −$0.52 | — | −$1.91 |
| 2015 | — | −$0.87 | — | −$0.37 | — | −$2.42 |
| 2016 | — | −$0.87 | — | −$0.10 | — | −$2.46 |
| 2017 | — | −$0.70 | — | −$0.01 | — | −$2.47 |
| 2018 | $0.00 | $0.01 | — | −$0.00 | — | — |
| 2019 | $0.01 | −$0.59 | — | −$0.04 | — | −$0.67 |
| 2020 | $0.03 | −$0.32 | — | $0.01 | — | −$0.98 |
| 2021 | $0.15 | −$0.24 | — | $0.08 | — | −$1.19 |
| 2022 | $0.06 | −$0.27 | — | $0.01 | — | −$1.46 |
| 2023 | $0.00 | −$0.52 | — | −$0.02 | — | −$1.99 |
| 2024 | $0.00 | −$0.11 | $0.00 | −$0.02 | — | −$1.73 |
| 2025 | $0.00 | −$0.20 | $0.00 | −$0.01 | — | −$1.90 |